Bacampicillin hydrochloride - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for bacampicillin hydrochloride and what is the scope of freedom to operate?
Bacampicillin hydrochloride
is the generic ingredient in one branded drug marketed by Pfizer and is included in two NDAs. Additional information is available in the individual branded drug profile pages.There are two drug master file entries for bacampicillin hydrochloride.
Summary for bacampicillin hydrochloride
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 2 |
Drug Master File Entries: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 39 |
Clinical Trials: | 1 |
Patent Applications: | 1,140 |
DailyMed Link: | bacampicillin hydrochloride at DailyMed |
Recent Clinical Trials for bacampicillin hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
James Graham Brown Cancer Center | Early Phase 1 |
Julio Ramirez | Early Phase 1 |
University of Louisville | Early Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for bacampicillin hydrochloride
US Patents and Regulatory Information for bacampicillin hydrochloride
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer | SPECTROBID | bacampicillin hydrochloride | TABLET;ORAL | 050520-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Pfizer | SPECTROBID | bacampicillin hydrochloride | TABLET;ORAL | 050520-002 | Sep 12, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Pfizer | SPECTROBID | bacampicillin hydrochloride | FOR SUSPENSION;ORAL | 050556-001 | Mar 23, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |